BrainCo
BrainCo develops brain-computer interface (BCI) technology and wearable devices that monitor, collect, and display real-time brain signal data, with applications spanning education, fitness, and neurological therapy. The company's product portfolio includes a prosthetic hand controlled by brain signals and an EEG headband device that monitors and collects the user's brain signal data, displaying real-time brain…
Funding snapshot
About
BrainCo develops brain-computer interface (BCI) technology and wearable devices that monitor, collect, and display real-time brain signal data, with applications spanning education, fitness, and neurological therapy. The company's product portfolio includes a prosthetic hand controlled by brain signals and an EEG headband device that monitors and collects the user's brain signal data, displaying real-time brain activity through a companion app. The headband is applicable across multiple domains: FocusEdu (designed to train students in primary and secondary education for cognitive training and attention improvement), FocusFit (to maximize workouts and recover faster through brain activity monitoring), and attenZOOM (cognitive training for students). BrainCo's technology enables users to understand and train their brain activity for improved focus, cognitive performance, and wellness outcomes. The companion app provides real-time feedback and brain activity visualization, making neurofeedback accessible to consumers rather than limited to clinical settings. The company differentiates itself through its combination of consumer-grade BCI wearables with practical applications across education, fitness, and healthcare, its prosthetic hand technology leveraging neural control, and its focus on making brain signal monitoring accessible and actionable for everyday users. Founded in 2015 and headquartered in the United States, BrainCo has raised approximately $291.8 million in a Series A round backed by Hantan Capital, Boston Angel Club, Wandai Capital, IDG Capital, Walden International, Lens Technology, OmniVision, Decent Capital, Raspberry, Tencent WeStart, Chifortune Venture Capital, and Rainmaking.
Business model
Brain Computer Interface > Applications > Fitness & Wellness,
Wearable Technology > Health and Wellness Devices > Mental Wellness,
Disease Self Management > Neurological Disorders > Therapy > Cognitive Training > Device > Wearable,
Fitness & Wellness Tech > Mind & Body Wellness > Stress Management > Devices,
Healthcare IT > Provider > Clinical Operations > Decision Support > Diagnosis > Differential Diagnosis > Electrodiagnostics > Neurology,
Neurology > Medical Devices > Screening Devices > Electrodiagnostic Testing > Home Based
Founders & team highlights
Founder with Prior Funding,
Serial Founder
Team background
Top Rated Teams > Serial Entrepreneur,
College Wise > Harvard University
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.